Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of helium/oxygen mixed gas for pediatric respiratory failure due to airway obstruction
jRCT2091220357Phase 2Completed
- Sponsor
- Tokyo Metropolitan Children's Medical Center
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of heliox in bronchiolitis, congenital tracheal stenosis (CTS), asthma and 1 more, sponsored by Tokyo Metropolitan Children's Medical Center. Primary endpoint: Ratio of serious side effects caused by AW-PD01. Started Jun 2018; status: completed.
02
Drugs
heliox
03
Conditions
bronchiolitiscongenital tracheal stenosis (CTS)asthmarespiratory failure
Beyond the preview
Go deeper on jRCT2091220357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220357.